PMC5966621_01
T2 weighted sequence after gadolinium infusion demonstrated mesocardiac late enhancement in the mid lateral wall (short axis view).
gr1.jpg
PMC5966621_01_gr1.jpg
fig0005
Cardiac Magnetic Resonance (CRM) was suggestive for myocarditis both on T1 and T2 studies and showed a mesocardiac late gadolinium enhancement in the lateral wall (Fig. 1).
Laboratory tests shows evolution of liver enzymes levels, ESV, RCP and haemachrome before and during ganciclovir therapy (*ganciclovir therapy started; ESV = erythrocyte sedimentation velocity; RCP = reactive c-protein; AST = serum glutamic oxaloacetic transaminase; ALT = serum glutamate-pyruvate transaminase; ALKP = alkaline phosphatase; GGT = gamma-glutamyltransferase).
gr2.jpg
PMC5966621_01_gr2.jpg
fig0010
On the sixth day of ganciclovir therapy added to standard heart failure (HF) therapy, the patient stabilized clinically; platelets, hemoglobin and reticulocytes began to raise up to normal values; ESR, CRP and transaminases normalized (Fig. 2).